Lazerib Tablets — Lazertinib 80 mg (90 Tabs) Everest

Prescribed by oncologists for the treatment of adult patients with:

• 🔹 Non-Small Cell Lung Cancer (NSCLC): Locally advanced or metastatic NSCLC with confirmed EGFR mutations (Exon 19 deletion, L858R substitution) or T790M mutation.

Sales Unit: Bottle in a box containing 90 film-coated tablets (80 mg strength). This provides exactly a 30-day supply.

⚠️ APPLICATION INSTRUCTIONS:

• Standard Dosage: 240 mg (three 80 mg tablets) taken orally once daily.
• Administration: Swallow tablets whole with water at the same time each day. Can be taken with or without food. Do not chew, crush, or split.
• ✋ Missed Dose: Take as soon as remembered unless the next dose is due within 12 hours. Do not take a double dose to make up for a missed one.

• ⛔ Pregnancy & Breastfeeding: Strictly contraindicated due to potential fetal harm.
• Hypersensitivity to Lazertinib.
• History of Interstitial Lung Disease (ILD) or pneumonitis.
• QT interval prolongation (heart rhythm disorder).

Regular cardiac monitoring (ECG) and lung assessments are recommended. Potential side effects include:

• ✋ Dermatologic: Paresthesia (tingling sensation), rash, pruritus, paronychia (nail infection).
• 🤢 Gastrointestinal: Decreased appetite, diarrhea, nausea.
• 💪 Musculoskeletal: Myalgia (muscle pain).
• 🤧 Respiratory: Dyspnea, cough (rarely pneumonitis).